Riskpilot← Back to searchSign inGet full accessHällöv & Co AB
ABActiveOrg 5566985171Raka Vägen 1Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20061 employees
Revenue 2025
SEK 1,5M
+18% vs 2024
EBITDA margin
-4.3%
+57% vs 2024
Equity ratio
89.8%
Financial strength
Net profit 2025
SEK -68K
+80% vs 2024
| Revenue | SEK 1,5M | +18% |
| EBITDA | SEK -67K | +57% |
| Net profit | SEK -68K | +80% |
| Total assets | SEK 1,4M | -8% |
| Equity | SEK 1,3M | -5% |
| Employees | 1 | — |
Legal name
Hällöv & Co AB
Org number
5566985171
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
20 februari 2006
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska bedriva konsultativ verksamhet med inriktning på företagsutveckling samt bedriva utveckling, handel och försäljning av utvecklade innovationer inom bolaget, äga och förvalta värdepapper samt därmed förenlig verksamhet.
Address
Raka Vägen 1
Phone
+46702268677
Email
niclas.hallov@miramed.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 275 | 2 358 | 2 751 | 1 303 | 1 543 |
| Staff expenses | — | −472 | −483 | −457 | −453 |
| EBITDA | −185 | 481 | 215 | −157 | −67 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −185 | 481 | 215 | −157 | −67 |
| Net financials | −3 | −3 | −2 | −319 | −1 |
| Profit before tax | −158 | 397 | 159 | −342 | −68 |
| Tax | −0 | −50 | −33 | — | — |
| Net profit | −158 | 347 | 126 | −342 | −68 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 1 444 | 2 007 | 2 131 | 1 531 | 1 404 |
| Equity | 1 229 | 1 575 | 1 701 | 1 329 | 1 261 |
| Long-term debt | 42 | 42 | 37 | 37 | 37 |
| Short-term debt | 173 | 308 | 259 | 166 | 107 |
| Total debt | 215 | 350 | 296 | 202 | 143 |
EBITDA margin
-4.3%
This company
15.8%
Market median
-127% vs market
20212025
Equity ratio
89.8%
This company
38.2%
Market median
+135% vs market
20212025
Return on equity
-5.4%
This company
18.4%
Market median
-129% vs market
20212025
Net profit margin
-4.4%
This company
8.1%
Market median
-154% vs market
20212025
Asset turnover
1.10×
This company
1.12×
Market median
+2% vs market
20212025
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LF Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Hällöv & Co AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Fredrik Niclas Hällöv | Chief Executive Officer | 0 companies |
| Anna Elisabeth Hällöv | Deputy Board Member | 0 companies |